← All indications
Carcinosarcoma
A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. (Stedman, 25th ed)
Subtype terms (1)
More specific conditions that are subtypes of Carcinosarcoma in the MeSH hierarchy.
Drugs by status
Phase 2 trials (20)
Organizations
Organization Involved with Phase 3 Indications (8)
Organization Involved with Phase 2 Indications (40)
- Takeda
- Bristol-Myers Squibb
- Clovis Oncology
- AstraZeneca
- Merck
- Genentech
- Sanofi
- GlaxoSmithKline
- Leap Therapeutics, Inc.
- Syndax Pharmaceuticals
- Zymeworks Inc.
- The Christie NHS Foundation Trust
- Medical University of Graz
- Cornell University
- Harvard University
- Medical College of Wisconsin
- North Eastern Germany Society of Gynaecologic Oncology
- Thomas Jefferson University
- University of Manchester
- University of Milan
- University of Oklahoma
- University of Toronto
- Mayo Clinic
- Cardiff University
- University of Chicago
- Vanderbilt University
- University of Texas at Houston
- University of Duisburg-Essen
- University of Alabama, Birmingham
- Washington University in St. Louis
- +10 more
Organization Involved with Phase 1 Indications (6)